OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Daniel Laskowitz

4 Projects | 1 Researchers | $374,262 Invested

2008

Duke University

Daniel Laskowitz, PhD

A novel apoE-derived therapeutic reduces AD pathology

  • Funding Amount: $85,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2006

Duke University

Daniel Laskowitz, PhD

A novel apoE-derived therapeutic reduces AD pathology

  • Funding Amount: $93,449
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2005

Duke University

Daniel Laskowitz, PhD

An ApoE-Derived Therapeutic Improves AD Pathology in a Murine Model following Head Injury - Year 2

  • Funding Amount: $93,449
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2004

Duke University

Daniel Laskowitz, PhD

The effect of ApoE mimetic therapeutic peptide in a murine model of AD.

  • Funding Amount: $102,364
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed